Company number 09376285
Status Active
Incorporation Date 6 January 2015
Company Type Private Limited Company
Address 70 NORDEN ROAD, MAIDENHEAD, BERKSHIRE, SL6 4AY
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc
Since the company registration thirteen events have happened. The last three records are Register(s) moved to registered inspection location 7 Albemarle Street London W1S 4HQ; Register inspection address has been changed to 7 Albemarle Street London W1S 4HQ; Confirmation statement made on 6 January 2017 with updates. The most likely internet sites of CONVERGENCE PHARMACEUTICALS LIMITED are www.convergencepharmaceuticals.co.uk, and www.convergence-pharmaceuticals.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and eleven months. Convergence Pharmaceuticals Limited is a Private Limited Company.
The company registration number is 09376285. Convergence Pharmaceuticals Limited has been working since 06 January 2015.
The present status of the company is Active. The registered address of Convergence Pharmaceuticals Limited is 70 Norden Road Maidenhead Berkshire Sl6 4ay. . GREEN, Steven John is a Director of the company. MILL, Trevor Anthony is a Director of the company. TATE, Simon Nicholas is a Director of the company. WATSON, David John is a Director of the company. The company operates in "Research and experimental development on biotechnology".
Current Directors
Persons With Significant Control
Biogen Inc.
Notified on: 6 April 2016
Nature of control: Ownership of shares – 75% or more
CONVERGENCE PHARMACEUTICALS LIMITED Events
12 Apr 2017
Register(s) moved to registered inspection location 7 Albemarle Street London W1S 4HQ
12 Apr 2017
Register inspection address has been changed to 7 Albemarle Street London W1S 4HQ
06 Mar 2017
Confirmation statement made on 6 January 2017 with updates
23 Jan 2017
Statement of capital following an allotment of shares on 11 February 2015
08 Dec 2016
Full accounts made up to 31 December 2015
...
... and 3 more events
08 Mar 2016
Appointment of Mr. David John Watson as a director on 30 March 2015
12 Jan 2016
Annual return made up to 6 January 2016 with full list of shareholders
Statement of capital on 2016-01-12
-
ANNOTATION
Clarification a second filed AR01 was registered on 07/09/2016
24 Apr 2015
Company name changed silver newco co LIMITED\certificate issued on 24/04/15
-
RES15 ‐
Change company name resolution on 2015-03-30
24 Apr 2015
Change of name notice
06 Jan 2015
Incorporation
Statement of capital on 2015-01-06
-
MODEL ARTICLES ‐
Model articles adopted (Amended Provisions)